[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604848":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":53,"collaborators":25,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":25,"eligibilityCriteria":62,"healthyVolunteers":59,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":25,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":25,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Ain Shams University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A:(Hydrocortisone group)","ACTIVE_COMPARATOR","• Group A: : received 2mg\u002Fkg.",[13],"Drug: Hydrocortisone",{"label":15,"type":10,"description":16,"interventionNames":17},"Group B: (Dexmedetomidine group)","• Group B: : received 1 µg\u002Fkg.",[18],"Drug: Dexmedetomidine",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Hydrocortisone","received 2mg\u002Fkg.",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Dexmedetomidine","received 1 µg\u002Fkg",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"maha SMD elDerh, M.D.","CONTACT","+20224190092","mahasadek81@yahoo.com",[37],{"facility":5,"status":38,"city":39,"state":25,"zip":25,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Cairo","Egypt","EG",{"type":43,"coordinates":44},"Point",[45,46],31.24967,30.06263,{"lat":46,"lon":45},[49],{"name":50,"role":33,"phone":51,"phoneExt":25,"email":52},"Fathy Tash, M.D.","202 2685 7539","Fathytash@yahoo.com",{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","maha sadek El Derh","assistant professor","100604848","phase-4-comparative-study-between-the-efficacy-of-intravenous-hydrocortisone-and-intravenous-dexmedetomidine-for-prevention-of-postoperative-shivering-after-general-anaesthesia-for-abdominal-surgeries-100604848",false,"NCT07154849","Comparative Study Between the Efficacy of Intravenous Hydrocortisone and Intravenous Dexmedetomidine for Prevention of Postoperative Shivering After General Anaesthesia for Abdominal Surgeries","Inclusion Criteria: any patient undergoing abdominal surgery ASAI or II.\n\n\\-\n\nExclusion Criteria:\n\n* Patients with known neurologic and psychiatric illness.\n* Uncontrolled diabetic patients.\n* Patients on long term steroid therapy.\n* Allergy to any of the drugs used in the study.\n* Pregnancy and lactation.\n* Hypo or hyperthyroidism.","ALL","18 Years","65 Years",{"count":67,"type":68},70,"ESTIMATED","INTERVENTIONAL",[71],"PHASE4","The aim and purpose of this study is to compare the efficacy of intravenous hydrocortisone and intravenous dexmedetomidine for prevention and treatment of postoperative shivering after general anesthesia for abdominal surgeries.",[74],"Shivering","2025-09-03",{"date":77,"type":78},"2025-09-04","ACTUAL",{"date":80,"type":78},"2024-11-11",{"date":82,"type":68},"2025-12-20",{"name":5,"class":6},1]